aap Implantate AG (AAQ1) — Strategic Asset Allocation Index
aap Implantate AG (AAQ1) has a Strategic Asset Allocation Index of 38.6% as of June 2022. Strategic assets (PP&E of €4.88 Million plus long-term investments of €-) total €4.88 Million, measured against net assets of €12.63 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
aap Implantate AG Strategic Asset Allocation Index (2016–2021)
This chart shows how aap Implantate AG's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of June 2022, the index stands at 38.6%, representing strategic assets of €4.88 Million against net assets of €12.63 Million EUR. Explore cash flow conversion of aap Implantate AG to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for aap Implantate AG (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for aap Implantate AG from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see AAQ1 market cap.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 40.8% | €5.21 Million | €5.21 Million | €- | €12.78 Million | ▼ -4.7 pp |
| 2020 | 45.5% | €4.68 Million | €4.68 Million | €- | €10.29 Million | ▲ +7.8 pp |
| 2019 | 37.7% | €7.11 Million | €7.11 Million | €- | €18.87 Million | ▲ +18.1 pp |
| 2018 | 19.6% | €6.85 Million | €6.85 Million | €- | €34.92 Million | ▲ +3.2 pp |
| 2017 | 16.4% | €6.98 Million | €6.98 Million | €- | €42.56 Million | ▲ +2.5 pp |
| 2016 | 13.9% | €7.62 Million | €7.62 Million | €- | €54.78 Million | — |